Home Study Details

    Program Type

    Home Study


    1 Contact Hour(s)

    Release Date

    Thursday, February 28, 2019

    Offline Date

    Saturday, August 28, 2021

    ACPE Expiration Date

    Monday, February 28, 2022

    Target Audience




    • Overview

      Chemotherapy induced nausea and vomiting (CINV) leads to morbidity and complications in care and occurs in up to 80% of patients. Despite the recent advances in newly available antiemetics, approximately 50% of patients experience CINV, which can have a severe effect on the cancer patient’s quality of life. In addition to CINV having a substantial negative impact on the patient’s quality of life, it can also lead to chemotherapy delays, dose reductions, or discontinuation of therapy. CINV can be a major barrier to therapy if not treated appropriately. With the development of therapy options in a wider range of classes, it is possible for more patients to better control their CINV. 


      • Homestudy PDF :   19137H01.pdf

      Financial Support By

    • Pharmacist

      Identify 4 toxicities to consider with antiemetic therapy agents
      Identify chemotherapy induced nausea and vomiting (CINV) risk factors of patients receiving chemotherapy
      List the antiemetic therapy agents available in the treatment of CINV
      Recommend an antiemetic regimen based on a patient's chemotherapy agent(s) and risk factors
    • Activity Type


      CE Broker


      Universal Activity Number

      Pharmacist 0798-0000-19-037-H01-P

      ACPE PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

      PharmCon is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

      In order to obtain a Statement of Credit, participants must score no less than a 70% on the activity's test and complete a program evaluation.

    Standard Windows/Mac System
    iPad or iPhone
    Minimum screen resolution: 1024x768
    Speakers or headphones

    Microsoft Edge
    Internet Explorer 8.0 or higher
    Google Chrome
    Firefox 3.0.3 or higher
    Adobe Acrobat Reader

    Broadband Internet Connection:
    T1, Hi-speed DSL or Cable
    4G cellular connection

    This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).